According to PolarityTE's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 24.3517. At the end of 2023 the company had a P/S ratio of 50.6.
Year | P/S ratio | Change |
---|---|---|
2023 | 50.6 | 765.79% |
2022 | 5.84 | 13.43% |
2021 | 5.15 | 39.76% |
2020 | 3.68 | -70.75% |
2019 | 12.6 | -93.97% |
2018 | 209 | -48.57% |
2017 | 406 | 6186.25% |
2016 | 6.46 | 255.08% |
2015 | 1.82 | 604.91% |
2014 | 0.2581 | -56.55% |
2013 | 0.5941 | 87.75% |
2012 | 0.3165 | -71.52% |
2011 | 1.11 | 243.15% |
2010 | 0.3238 | -6.7% |
2009 | 0.3470 | 33.79% |
2008 | 0.2594 | -70.48% |
2007 | 0.8786 | 101.68% |
2006 | 0.4356 | -30.79% |
2005 | 0.6295 | -71.18% |
2004 | 2.18 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |